112 related articles for article (PubMed ID: 31095784)
21. Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.
Islam BN; Sharman SK; Hou Y; Bridges AE; Singh N; Kim S; Kolhe R; Trillo-Tinoco J; Rodriguez PC; Berger FG; Sridhar S; Browning DD
Cancer Prev Res (Phila); 2017 Jul; 10(7):377-388. PubMed ID: 28468928
[TBL] [Abstract][Full Text] [Related]
22. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
23. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
24. Combined Analysis of Human and Experimental Murine Samples Identified Novel Circulating MicroRNAs as Biomarkers for Atrial Fibrillation.
Natsume Y; Oaku K; Takahashi K; Nakamura W; Oono A; Hamada S; Yamazoe M; Ihara K; Sasaki T; Goya M; Hirao K; Furukawa T; Sasano T
Circ J; 2018 Mar; 82(4):965-973. PubMed ID: 29398686
[TBL] [Abstract][Full Text] [Related]
25. Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel.
Im SA; Kim JW; Kim HS; Park CS; Shin E; Do SG; Park YI; Lee CK
Int Immunopharmacol; 2016 Nov; 40():428-435. PubMed ID: 27697726
[TBL] [Abstract][Full Text] [Related]
26. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
27. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
29. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
Wang YN; Chen ZH; Chen WC
Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA‑449a is a potential predictor of colitis‑associated colorectal cancer progression.
Feng Y; Dong YW; Song YN; Xiao JH; Guo XY; Jiang WL; Lu LG
Oncol Rep; 2018 Sep; 40(3):1684-1694. PubMed ID: 30015944
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of DKK3 by miR-483-3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins.
Guo J; Yang Z; Zhou H; Yue J; Mu T; Zhang Q; Bi X
Mol Carcinog; 2020 Feb; 59(2):168-178. PubMed ID: 31763724
[TBL] [Abstract][Full Text] [Related]
32. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers.
Jamali L; Tofigh R; Tutunchi S; Panahi G; Borhani F; Akhavan S; Nourmohammadi P; Ghaderian SMH; Rasouli M; Mirzaei H
J Cell Physiol; 2018 Nov; 233(11):8538-8550. PubMed ID: 29923196
[TBL] [Abstract][Full Text] [Related]
34. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
36. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
37. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
[TBL] [Abstract][Full Text] [Related]
38. Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer.
Tan YG; Zhang YF; Guo CJ; Yang M; Chen MY
Asian Pac J Trop Med; 2013 Dec; 6(12):972-6. PubMed ID: 24144030
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
40. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
